Immunogenicity Profile of a 3.75-μg Hemagglutinin Pandemic rH5N1 Split Virion AS03(A)-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial

Background. Elderly persons often experience a reduced immune response to influenza vaccination. We evaluated the usual dose of AS03(A)-adjuvanted H5N1 pandemic vaccine (3.75 μg hemagglutinin of A/Vietnam/1194/2004-like strain) compared with a double dose in an elderly population. Methods. This phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Heijmans, Stéphane, De Meulemeester, Marc, Reynders, Paul, Giet, Didier, Demanet, Etienne, Devresse, Pierre-Yves, Icardi, Giancarlo, Dramé, Mamadou, Roman, François, Gillard, Paul
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068020/
https://www.ncbi.nlm.nih.gov/pubmed/21450995
http://dx.doi.org/10.1093/infdis/jiq174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068020/
https://www.ncbi.nlm.nih.gov/pubmed/21450995
http://dx.doi.org/10.1093/infdis/jiq174

Ejemplares similares